<?xml version="1.0" encoding="UTF-8"?><protocol_summary><protocol><id>16041</id><no>PRELUDE-IIT-NCT06798558</no><status>Open</status><title>Phase II Study of Neoadjuvant Lu-177PSMA-617 in Patients with High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy</title><nct_id>NCT06798558</nct_id><sponsor_type>Industrial; Institutional</sponsor_type><age_group>Adult</age_group><treatment_type>Treatment</treatment_type><phase>II</phase><disease_site>Other</disease_site><PI>Leger, Paul</PI><institution>Lombardi Comprehensive Cancer Center : Alan Zwart; Medstar Washington Hospital Center</institution><oncology_group>Genito-urinary<DOWG_name>Oncology Group</DOWG_name></oncology_group><management_group>Lombardi Comprehensive Cancer Center (LCCC)</management_group><item><contact_id>16795</contact_id><item_description>Alan Zwart</item_description><js_safe_str>Alan Zwart</js_safe_str><email>az6@georgetown.edu</email></item></protocol><sipVersion>2026.1.0 Build 16</sipVersion><copyright> &lt;a href="https://advarra.com" target="_blank"&gt;&amp;copy; 2026 Advarra, Inc.&lt;/a&gt; </copyright></protocol_summary>